This compound is a salt-form pharmaceutical intermediate used in the production of bromhexine derivatives. It features a complex polycyclic structure containing amine, alcohol, and halogen functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ambroxol EP Impurity B
pharmaceutical intermediate
(S)-4-Boc-Piperazine-3-carboxylic acid
pharmaceutical intermediate
Benzyl (2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoate;hydrochloride
pharmaceutical intermediate
6-Azido-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-norleucine
pharmaceutical intermediate
(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid
pharmaceutical intermediate
Ambroxol Cyclic Impurity-d5 Dihydrochloride
pharmaceutical impurity standard for research
4-(6,8-dibromo-2,4-dihydro-1H-quinazolin-3-yl)cyclohexan-1-ol;hydrochloride
ICLHRFYBPXBCPE-UHFFFAOYSA-N
C1CC(CCC1N2CC3=C(C(=CC(=C3)Br)Br)NC2)O.Cl
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.